As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ... Jun 13
Latest news updates... Oct 26
Latest Pharma Update... Aug 23
Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
Another pharma collaboration for the advancement of cancer therapies ... Mar 22
BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
... Dec 16
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMTâ„¢ in combination with immune ... Oct 21
PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease... Sep 22
Binex will produce olinvacimab at its new 5,000L production line... Sep 03
Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours ... Jul 31
PharmAbcine signs long-term contract manufacturing organization agreement for Olinvacimab with Binex ... Jun 27
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ... May 14
... Sep 13
First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)